Related Experiment Videos
Neurologic complications in galactosemia.
T K Koch1, K A Schmidt, J E Wagstaff
1Department of Pediatrics, University of California, San Francisco 94143.
Pediatric Neurology
|May 1, 1992
Summary
Even with early diagnosis and treatment for galactosemia, individuals may experience significant neurological issues. This suggests potential biochemical differences or insufficient metabolites for proper myelin development.
Area of Science:
- Biochemistry
- Neurology
- Genetics
Background:
- Galactosemia is an inherited metabolic disorder.
- Classic transferase deficiency galactosemia requires strict lactose restriction from birth.
- Early diagnosis and dietary management are standard treatment protocols.
Observation:
- Two siblings with classic transferase deficiency galactosemia presented with progressive neurological decline despite dietary management.
- Clinical manifestations included mental retardation, hypotonia, hyperreflexia, dysarthria, ataxia, and tremors.
- MRI revealed cortical atrophy, absent myelination, and white matter abnormalities.
Findings:
- Galactosemia can lead to significant neurological morbidity even with early treatment.
- Abnormalities in white matter development were observed.
- Potential biochemical heterogeneity within galactosemia subtypes or impaired glycolipid synthesis impacting myelination is suggested.
Implications:
- This study highlights the potential for severe neurological complications in galactosemia patients.
- Findings suggest a need to explore biochemical variations and their impact on myelin development.
- Further research into galactose metabolism and its role in neurological health is warranted.